Product Details for: Phesgo Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Label Grayed out Product Label links indicate that there is no product label available for the product.
Product Number | Dosage Form | Route of Administration | Strength | Product Presentation | License Type | Proprietary Name | Marketing Status |
---|---|---|---|---|---|---|---|
001 | Injection | Subcutaneous | 1,200MG, 600MG, 30,000UNITS/15ML (80MG, 40MG, 2,000UNITS/ML) | Single-Dose Vial | 351(a) | Phesgo | Rx |
002 | Injection | Subcutaneous | 600MG, 600MG, 20,000UNITS/10ML (60MG, 60MG, 2,000UNITS/ML) | Single-Dose Vial | 351(a) | Phesgo | Rx |
Proper Name
pertuzumab, trastuzumab, and hyaluronidase-zzxf
BLA Number
761170
Applicant
Genentech, Inc.
Original Approval Date
June 29, 2020
Date of First Licensure